A Auerbach Selected Research

neratinib

1/2019

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Auerbach Research Topics

Disease

1	Neoplasms (Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Diarrhea 01/2019
1	Edema (Dropsy) 09/2006
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 06/2001
1	Huntington Disease (Huntington's Disease) 11/2000
1	Peritonitis 09/2000
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 09/2000

Drug/Important Bio-Agent (IBA)

1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	neratinibIBA 01/2019
1	GadoliniumIBA 09/2006
1	Uroplakin IIIIBA 06/2001
1	Huntingtin ProteinIBA 11/2000
1	Glutamine (L-Glutamine)FDA Link 11/2000
1	AntigensIBA 09/2000
1	Choline (Choline Chloride)IBA 09/2000

Therapy/Procedure

1	Therapeutics 01/2019